Cargando…
Burden of upper gastrointestinal symptoms in patients prescribed dabigatran for stroke prevention
BACKGROUND: Dabigatran, a non-vitamin K antagonist oral anticoagulant, has been shown to prevent stroke in patients with non-valvular atrial fibrillation. Nonetheless, studies show that 10%–30% of those prescribed dabigatran experience dyspepsia that may eventually lead to discontinuation of therapy...
Autores principales: | Chan, Pak-Hei, Hai, Jo-Jo, Huang, Duo, Ho, Mei-Han, Chan, Esther W, Cheung, Bernard Man-Yung, Chan, Annie On-On, Wong, Ian Chi-Kei, Tse, Hung-Fat, Hung, Ivan Fan-Ngai, Siu, Chung-Wah |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4976790/ https://www.ncbi.nlm.nih.gov/pubmed/27551422 http://dx.doi.org/10.1177/2050312116662414 |
Ejemplares similares
-
Continuation of Dabigatran Therapy in “Real-World” Practice in Hong Kong
por: Ho, Mei Han, et al.
Publicado: (2014) -
Quinidine for Brugada syndrome: Panacea or poison?
por: Hai, Jo-Jo, et al.
Publicado: (2016) -
Impact of Antithrombotic Therapy in Atrial Fibrillation on the Presentation of Coronary Artery Disease
por: Chan, Pak Hei, et al.
Publicado: (2015) -
Prediction of Thromboembolic Events in Heart Failure Patients in Sinus Rhythm: The Hong Kong Heart Failure Registry
por: Hai, Jo-Jo, et al.
Publicado: (2016) -
Use of the SAMe-TT(2)R(2) Score to Predict Good Anticoagulation Control with Warfarin in Chinese Patients with Atrial Fibrillation: Relationship to Ischemic Stroke Incidence
por: Chan, Pak Hei, et al.
Publicado: (2016)